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Summary
 
Recent studies have shown that many nonclassical major histocompatibility complex (MHC)
(class Ib) molecules have distinct antigen-binding capabilities, including the binding of nonpep-
tide moieties and the binding of peptides that are different from those bound to classical MHC
molecules. Here, we show that one of the H-2T region–encoded molecules, T10, when pro-
duced in 
 
Escherichia coli
 
, can be folded in vitro with 
 
b
 
2
 
-microglobulin (
 
b
 
2
 
m) to form a stable
heterodimer in the absence of peptide or nonpeptide moieties. This heterodimer can be recog-
nized by specific antibodies and is stimulatory to the 
 
gd
 
 T cell clone, G8. Circular dichroism
analysis indicates that T10/
 
b
 
2
 
m has structural features distinct from those of classical MHC class
I molecules. These results suggest a new way for MHC-like molecules to adopt a peptide-free
structure and to function in the immune system.
 
C
 
lassical MHC class I (class Ia) molecules possess a
highly specialized groove occupied by short peptides
that are acquired inside the cell during MHC heterodimer
assembly. This peptide–MHC interaction not only contrib-
utes to the stability of the heterodimer on the cell surface,
but forms the basis for its function, as complexes of intra-
cellular pathogen derived peptides with MHC are the
ligands for cytolytic 
 
ab
 
 T cells. Recently, many nonclassi-
cal MHC class I molecules, such as those encoded in the Q,
T, M, and CD1 regions, have been found to possess bind-
ing properties different from those of classical MHC mole-
cules (as reviewed in references 1 and 2). These studies sug-
gest that class Ib molecules have evolved for specific tasks
that are distinct from those of classical class I MHC. For ex-
ample, M3 and human CD1 have been proposed to play a
special role in controlling microbial infection by binding
and presenting 
 
N
 
-formylated peptide and lipid antigens, re-
spectively (3–7). Murine CD1 molecules have been shown
to bind hydrophobic peptides and are thought to stimulate
regulatory 
 
ab
 
 T cells (8, 9). Some Qa molecules were
found to bind mixtures of peptides with molecular proper-
ties different from those bound to classical MHC molecules
(10, 11). Other Qa molecules have been suggested to have
roles in the generation of regulatory T cells, as well as the
elimination of bacterially infected cells (12, 13).
Although the majority of the cells that respond to class Ib
ligands bear the 
 
ab
 
 TCR, the H-2T–encoded T10 and the
closely related T22 (94% identity) proteins were first iden-
tified as the ligands for two 
 
gd
 
 T cells, KN6 and G8 (14–
16). G8 was generated by immunizing BALB/c nude mice
with B10.BR spleen cells (17), whereas KN6 was derived
from a C57BL/6 double-negative thymocyte (18). At-
tempts to derive 
 
ab
 
 T cells specific for these molecules, us-
ing either cells naturally expressing T10/T22 or transfected
with these genes as immunogen, have been unsuccessful
(reference 19; Schild, H., and Y.-h. Chien, unpublished
data). Analysis of the recognition of T10/T22 by G8 shows
it to be clearly different from MHC class I recognition by
 
ab
 
 T cells. In particular, G8 can respond to stimulator cells
that lack functional peptide-loading mechanisms for either
MHC class I or class II molecules (15, 16, 19). All varia-
tions in the ability of different stimulator cells to activate
G8 can be attributed solely to the level of T10/T22 surface
expression. In addition, G8 is able to respond to T10/T22
expressed on 
 
Drosophila melanogaster
 
 cells, which inherently
lack peptide-loading machinery and therefore express MHC
molecules that are devoid of peptide (20). Together, these
experiments indicated that T10/T22 may not present pep-
tide for its recognition by G8.
In this study, we evaluate directly whether components
other than the T10/T22 heavy chain and 
 
b
 
2
 
-microglobulin
(
 
b
 
2
 
m) are necessary for its recognition and structural stabil-
ity. We find that 
 
Escherichia coli
 
–produced T10 and 
 
b
 
2
 
m can
be folded in vitro in the absence of peptide or nonpeptide
moieties. This is in contrast with classical class I MHC mol-
ecules, whose folding of 
 
E. coli
 
–produced heavy chain and
 
b
 
2
 
m can take place only in the presence of an appropriate
peptide (21, 22). The reconstituted T10/
 
b
 
2
 
m heterodimer
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is biochemically homogeneous and can be recognized by
specific antibodies and the G8 
 
gd
 
 T cell. The far-UV cir-
cular dichroic (CD)
 
1
 
 spectrum of T10/
 
b
 
2
 
m is different
from that of typical MHC class I molecules. These data
suggest that T10 may have evolved to possess distinctive
structural features capable of carrying out a specialized
function in the immune system.
 
Materials and Methods
 
Construction of Expression Vectors.
 
The expression cassettes for
T10 and T10/L
 
d
 
 (T10/L
 
d
 
, which has the 
 
a
 
1 and 
 
a
 
2 domains of
T10 and 
 
a
 
3 domain of the murine class I molecule L
 
d
 
, can be
recognized by the L
 
d
 
 
 
a
 
3-specific antibody 28.14.8S and G8. This
hybrid gene was constructed previously to monitor cell surface
expression of T10 in transfected cells in the absence of a T10/T22
heavy chain–specific antibody; reference 15) were constructed using
PCR and the oligonucleotide primers GGAATTCCCATATGG-
GTTCACACTCGCTTAGG and GCGCAAGCTTTTACC-
ATCTCAGGGTGAGGG containing the underlined EcoRI,
NdeI, and HindIII restriction sites, respectively. The NdeI site in
the EcoRI–NdeI oligonucleotide provides an ATG start codon
and a stop codon TAA is included in the HindIII oligonucleotide
to terminate the heavy chain following the 
 
a
 
3 domain COOH-
terminal tryptophan. The PCR was performed with the Ultma
 
Ô
 
polymerase (Perkin Elmer, Norwalk, CT) and the recommended
protocol. Amplified DNAs were ligated into pBluescriptKS(
 
1
 
)
(Stratagene, La Jolla, CA) as EcoRI–HindIII fragments. Upon
verification of the sequences, the heavy chain genes were ligated
into pET24a
 
1
 
 (Novagen, Madison, WI) as NdeI–HindIII frag-
ments and expressed in 
 
E. coli
 
 BL21(DE3)pLysS. Clones contain-
ing inserts and producing protein upon induction with isopropyl
 
b
 
-
 
d
 
-thiogalactopyranoside (IPTG) were identified for large cul-
ture. The human HLA-A2 and human 
 
b
 
2
 
m expression constructs
are described in Garboczi et al. (22). The murine 
 
b
 
2
 
m expression
construct is described in Young et al. (23).
 
Protein Production and Purification.
 
1 L of Cells transformed with
either heavy chain construct was grown to an OD
 
600
 
 of 0.3 and
induced for 2 h with 1 mM IPTG. The harvested cells were re-
suspended in 10 ml of 25% sucrose, 50 mM Tris, pH 8.0, 1 mM
EDTA, 1 mM PMSF, 1 mM DTT, and lysed at 37
 
8
 
C with 1%
Triton X-100 and 1 mg/ml lysozyme (Sigma Chem. Co., St.
Louis, MO) followed by freeze/thawing. The lysate was incu-
bated for 30 min at 25
 
8
 
C with 30 mM MgCl
 
2
 
 and 30 
 
m
 
g/ml
DNase (DN-25; Sigma) followed by the addition of 50 mM
EDTA. Inclusion bodies were collected by centrifugation and
washed 4–6 times with 20 ml of wash buffer containing 0.5%
Triton X-100, 50 mM Tris, pH 8.0, 100 mM NaCl, and 0.1%
NaN
 
3
 
. After two final washes in 20 ml of 50 mM Tris, pH 8.0,
100 mM NaCl, the inclusion bodies were solubilized in 6 M
guanidine–HCl, 100 mM Tris, pH 8.0, 1 mM EDTA. HLA-A2,
human 
 
b
 
2
 
m (h
 
b
 
2
 
m), and murine 
 
b
 
2
 
m (m
 
b
 
2
 
m) were expressed
and inclusion bodies isolated as described (22, 23). Subunits for
the T10/h
 
b
 
2
 
m folding were size-purified on a Superdex 200 col-
umn (Pharmacia, Uppsala, Sweden) in the presence of 6 M urea.
Before folding, 0.3 M DTT was added to all subunits.
 
Folding and Purification of the Heavy Chain–
 
b
 
2
 
m Complexes. 
 
Fold-
ing of the heterodimer was initiated by a 100-fold dilution of sub-
units into 1 L of nitrogen-saturated folding solution: 100 mM
Tris, pH 8.0, 0.4 M 
 
l
 
-arginine, 4 mM oxidized glutathione, 2
mM EDTA, 0.5 mM PMSF for T10/L
 
d
 
/h
 
b
 
2
 
m or T10/h
 
b
 
2
 
m and
100 mM Tris, pH 8.2, 25% glycerol, 4 mM oxidized glutathione,
2 mM EDTA, 0.5 mM PMSF for T10/m
 
b
 
2
 
m. Final protein con-
centrations were 1 
 
m
 
M T10 heavy chain and 2 
 
m
 
M 
 
b
 
2
 
m. Folding
reactions were incubated at room temperature for 48 h and con-
centrated to 30 ml in an Amicon stirred cell (10 kD cutoff) for
fractionation on a Superdex 200 column (Pharmacia). Fractions
containing associated T10/L
 
d
 
 heavy chain and h
 
b
 
2
 
m were identi-
fied using a sandwich ELISA. The ELISA-positive fractions for
T10/L
 
d
 
 and the corresponding sized fractions for T10/h
 
b
 
2
 
m or
T10/m
 
b
 
2
 
m were each concentrated 
 
z
 
10 times and subjected to a
Mono Q
 
Ô
 
 (Pharmacia) anion exchange column with a linear
gradient of 0.1–0.3 M NaCl in 20 mM Tris (pH 7.5). The esti-
mated yields of properly folded T10/h
 
b
 
2
 
m and T10/m
 
b
 
2
 
m are
2–4% and 1%, respectively.
The folding of HLA-A2 with HIV 
 
pol
 
 peptide RT309-317
(ILKEQVHGV) was carried out as described (22) with a folding
yield routinely 
 
z
 
8%. No heterodimer could be detected when
HLA-A2 and 
 
b
 
2
 
m were folded in the absence of peptide.
 
ELISA.
 
The sandwich ELISA for folded T10/L
 
d
 
/h
 
b
 
2
 
m het-
erodimer was performed using Immulon IV plates (Dynatech
Laboratories, Inc., Chantilly, VA) coated overnight at 4
 
8
 
C with
10 
 
m
 
g/ml 28.14.8S antibody. After a 1-h incubation with analyte
at room temperature, a rabbit anti–human 
 
b
 
2
 
m polyclonal serum
(Boehringer Mannheim, Indianapolis, IN) was added. The assay
was developed with a goat anti–rabbit alkaline phosphatase con-
jugate (Jackson ImmunoResearch Labs., West Grove, PA).
 
G8 Stimulation Assay.
 
G8 stimulation assays were performed
in high binding polystyrene plates (Costar, Cambridge, MA)
coated overnight at 4
 
8
 
C with purified T10/
 
b
 
2
 
m complex, moth
cytochrome 
 
c
 
 peptide 88–103 loaded I-E
 
k
 
, or using T10/L
 
d
 
 trans-
fected CHO cells for stimulation of 10
 
5
 
 G8 cells per well. Assays
were also performed with T10/h
 
b
 
2
 
m and T10/mb2m proteins
that had been coated overnight at 48C followed by a 10-h incu-
bation with either PBS containing 2% BSA or RPMI containing
10% FCS at 228C. The 24-h assay was carried out at 37 or 338C
for T10/hb2m and T10/mb2m, respectively. G8 cells express an
alkaline phosphatase gene under control of the IL-2 gene NFAT
promoter/enhancer (15). G8 stimulation is measured in fluorescence
units, which represent measurements of NFAT-specific alkaline
phosphatase activity, using the fluorescent substrate 4-methylum-
belliferyl phosphate (Sigma). The dose–response curves are repre-
sentative of at least three independent experiments.
Circular Dichroism Spectroscopy and Thermal Denaturation Studies.
Far-UV CD spectra were recorded in a 0.1 path length cell on an
AVIV 60 DS spectropolarimeter (Aviv Associates, Inc., Lake-
wood, NJ) equipped with a thermoelectric cuvette holder, using
a step size of 0.25 nm, a bandwidth of 1 nm, and a time constant
of 1 s. Spectra were recorded in sodium phosphate buffer (5 mM,
pH 7.0). The spectra shown are representative of 3–5 independent
measurements (each obtained from five repetitive scans) and were
smoothed by the Savitzky–Golay algorithm using a sliding win-
dow of 9 (2.25 nm). Far-UV CD data is given as [U]r, the mean
residue ellipticity. Thermal denaturation curves were obtained by
following the CD signal at 223 nm as a function of the tempera-
ture. The temperature was increased in a step-wise mode (28C
intervals) with each temperature jump being followed by a 30-s
equilibration time. Recording time was 100 s. Each point in the
melting curves shown in the text represents the average of three
independent experiments. Reversibility of the thermal transitions
was determined by standard heating/cooling cycles. In each such
1Abbreviations used in this paper: CD, circular dichroic; FcRn, rat neonatal
Fc receptor; IPTG, isopropyl b-d-thiogalactopyranoside.1225 Crowley et al.
cycle, spectra were initially recorded at 258C and the samples
were heated to temperatures above the Tm of the protein com-
plex analyzed and immediately cooled to 258C. Posttransition
spectra were recorded after an equilibration period of 1 h. The
CD spectra at high temperatures were recorded separately to
avoid the formation of kinetically driven, irreversibly unfolded
species due to long incubation times at high temperatures.
Thermodynamic parameters were derived from the CD data
presented in the text, assuming a two-state unfolding model.
Derivation of the free energy change, DG, at physiological tem-
perature (378C), which lies below the transition region of the un-
folding curves where the equilibrium constant, K, cannot be directly
derived, was made using the following form of the Gibbs–Helm-
holtz equation: DG(T) 5 DHm(1 2 T / Tm) 2 DCp([Tm 2 T] 1
Tln [T / Tm]), where T is the Kelvin temperature, Tm is the mid-
point temperature of the thermal unfolding transition, DHm is the
enthalpy change for unfolding measured at Tm, and DCp is the
difference in heat capacity between the folded and unfolded con-
formations. Tm and DHm were obtained from the van’t Hoff equa-
tion: DH 5 RT2(dlnK)/(dT), in which R is the gas constant. DHm
values used to derive the free energy of the two T10 forms were
96 and 85 kcal/mol for the human–mouse and mouse–mouse
combinations, respectively. DCp values were assumed to be inde-
pendent of temperature (24) and were estimated from the follow-
ing: DCp5 (dDH)/(dT)p. An average value of 0.8 kcal/mol ? deg
was used in all calculations. Values of K(T) inside the transition
region of the unfolding curves were derived from the following
relation: K(T) 5 (UN 2 UT) / (UT 2 UU), where (UN) and (UU)
are the limiting ellipticity values representing the native and un-
folded states, respectively, and (UT) is the observed ellipticity at
T. Baseline corrections of the row ellipticity values were made
only for data below the transition zone. The end product of the
main unfolding transition was represented by a single molar ellip-
ticity value.
Figure 1. Purification of reconstituted T10/b2m heterodimer by ion exchange chromatography. (A) SDS-PAGE analysis of T10 heavy chain (lane 1)
and hb2m (lane 2) in urea, a 0.25 M NaCl ion exchange column peak fraction from the T10/hb2m purification (lane 3), and a 0.5 M NaCl high salt wash
ion exchange column fraction (lane 4). Subunits in lanes 1 and 2 have been size purified in 6 M urea after solubilization in guanidine–HCl. The gel was
stained with Coomassie blue. (B) SDS-PAGE analysis of T10 heavy chain (lane 1) and mb2m (lane 2) solubilized in guanidine–HCl, a 0.27 M NaCl ion
exchange column peak fraction from the T10/mb2m purification (lane 3), and a 0.5 M NaCl high salt wash ion exchange column fraction (lane 4). The
gel was stained with Coomassie blue. (C) Ion exchange chromatography profile from the T10/hb2m heterodimer purification. Two major peaks, one at
0.25 M NaCl in the 0.1–0.3 M NaCl gradient and a second peak eluting at 0.5 M NaCl in the high salt wash, are observed.1226 T10 Does Not Bind Peptide and Is Recognized Directly by gd T Cell G8
Results
E. coli–produced T10 and b2m Subunits Can Be Folded into
a Stable Heterodimer in the Absence of Peptide. It was shown
previously that T10/T22 protein can be expressed stably
on cells lacking a functional peptide-loading mechanism
(15, 16, 19). In addition, incubation of T10/Ld-expressing
cells with peptide libraries of 8 amino acids in length or
shorter does not increase the level of surface T10/Ld ex-
pression (Schild, H., M. Jackson, and Y.-h. Chien, unpub-
lished data). These results suggest that T10/T22 may not
require peptide binding for stable expression on the cell
surface at physiological temperature. The fact that T10/
T22 expressed on these peptide loading–deficient cells can
stimulate G8 as well as those molecules expressed on nor-
mal cells further suggests that a peptide-free form of these
molecules is functional. To evaluate definitively whether
T10 and b2m without peptide are sufficient for maintaining
the structural stability and function of the complex, we ex-
pressed both components separately in E. coli, purified and
denatured each component, and folded them together in
vitro.
To detect properly folded material in the absence of an
anti-T10/T22 antibody or a suitable mouse b2m antibody,
we first perfomed folding experiments with a soluble form
of the chimeric T10/Ld heavy chain molecule and human
b2m. T10/Ld, which has the a1 and a2 domains of T10
and a3 domain of the murine class I molecule Ld, can stim-
ulate G8 and can be recognized by the Ld a3-specific anti-
body 28.14.8S (15). Human b2m can be recognized by an
anti-hb2m polyclonal serum.
Soluble forms of the T10/Ld and T10 heavy chain pro-
teins were produced by truncating the extracellular do-
mains just before the transmembrane region. All proteins
(T10, T10/Ld, hb2m, and mb2m) were produced as inclu-
sion bodies and, thus, they could be isolated to a high level
of purity by standard washing procedures (Fig. 1, A and B).
For the folding of T10/hb2m, subunits were subjected to
gel filtration in the presence of 6 M urea to further purify
heavy chain and hb2m away from residual bacterial compo-
nents (Fig. 1 A). The folding of subunits (T10/Ld with
hb2m, T10 with hb2m, and T10 with mb2m) was initiated
by dilution of the denatured subunits according to modi-
fied published procedures (22, 25). To isolate heterodimer,
the folding reactions were concentrated and fractionated by
gel filtration chromatography. Fractions containing the rena-
tured T10/Ld/hb2m were detected by a sandwich ELISA.
Corresponding fractions from the T10/hb2m or T10/mb2m
foldings were combined and the heterodimers were further
purified by ion exchange chromatography. In a gradient of
0.1–0.3M NaCl, a major peak eluting at 0.25 M NaCl or at
0.27 M NaCl was observed for the T10/hb2m and T10/
mb2m, respectively, while the rest of the protein eluted in
the 0.5 M NaCl high salt wash (Fig. 1 C; data not shown).
In each case, SDS-PAGE indicated that the major peak
within the gradient contained both the heavy chain and
b2m, whereas fractions from the high salt wash contained
heavy chain alone (Fig. 1, A and B).
Fractions from the ion exchange column were assayed
for their ability to stimulate G8 gd T cells. For all het-
erodimer purifications, only the material eluting within the
major peak in the gradient was active in these assays. The
folded T10/hb2m complex was found to stimulate G8 to
the same degree as T10/Ld transfected CHO cells (Fig. 2
A), which stimulate G8 to a higher level than the naturally
expressing EL4 or PCC3 cells (15). The T10/mb2m com-
plex was also stimulatory (Fig. 2 B), but at an z10-fold
lower level.
The lower stimulatory activity of T10/mb2m in these
experiments is most likely due to its lower thermal stability
compared with that of the T10/hb2m form (as discussed
below). This could cause T10/mb2m to be more sensitive
to the denaturing effects of the coating process (26). We
have preincubated T10/hb2m and T10/mb2m with media
Figure 2. (A) Stimulation of G8 gd T cells by purified T10/hb2m het-
erodimer and by CHO T10/Ld cells. (B) Stimulation of G8 gd T cells by
purified T10/mb2m heterodimer and by the moth cytochrome c 88–103
peptide-loaded MHC class II molecule, I-Ek.1227 Crowley et al.
at 228C for 10 h before T cell stimulation assays. This treat-
ment does not change the dose–response curves for either
complex compared with those without preincubation. To-
gether, these results clearly indicate that the complex has
been correctly folded and can be recognized by G8, with-
out the addition of peptide or nonpeptide components and,
likely, without the contribution of a media or serum com-
ponent.
T10/b2m Is Structurally Different from Classical MHC Class
I Molecules. Far-UV CD spectroscopy has been used to
analyze the structure and thermal stability of classical MHC
class I molecules and the rat neonatal Fc receptor (FcRn),
an MHC-like molecule that functions as an IgG transporter
(27–31). To obtain similar parameters for the reconstituted
T10/b2m heterodimer, we subjected both T10/hb2m and
T10/mb2m to CD analysis (Fig. 3, data not shown). Inter-
estingly, the spectra of both T10/hb2m and T10/mb2m are
red-shifted compared with those reported for classical MHC
class I molecules and FcRn (27–31). This difference was
further verified by comparing the CD spectrum of T10
with that of E. coli–expressed and folded HLA-A2 mole-
cules complexed with HIV pol peptide (Fig. 3). These data
suggest that although these molecules are likely to have
similar folds, T10 has structural properties distinct from
classical class I MHC molecules (32).
The thermal denaturation profile of the T10/hb2m com-
plex is shown in Fig. 4 A. At neutral pH , the melting curve
reveals two transitions. The first is characterized by a transi-
tion temperature midpoint (Tm) of 498C and reflects the si-
multaneous dissociation and unfolding of the T10 heavy
chain. The second transition, with a Tm at 63–648C, is charac-
terized by a sign reversal of the CD signal and closely paral-
lels the unfolding profile of free b2m (Tm < 648C, data not
shown; references 29, 30), implying that its denaturation is
largely independent of the heavy chain. Consistent with its
lower activity in G8 stimulation assays, the T10/mb2m com-
plex is less stable than the mouse–human combination, with a
Tm 5 438C (Fig. 5). Mouse b2m was observed to have a
Tm < 628C (data not shown). For each heterodimer, the
thermal transition is largely reversible (see Fig. 4 B; data not
shown).
Assuming a standard two-state unfolding model, the free
energy change at a particular temperature, DG(T), can be
estimated from the melting curves shown here. At physio-
logical temperature (378C), we calculate free energy changes
of z3.3 and 1.5 kcal/mol for the T10/hb2m and T10/
mb2m heterodimers, respectively. These values for T10/
hb2m and T10/mb2m can be translated into expected ratios
of folded to unfolded species of 200:1 and 11:1, respec-
tively, at 378C. The structural basis for the different thermal
stabilities of these heterodimers is presently under investi-
gation.
By comparison, both forms of T10 are less stable than
classical class I molecules complexed with an appropriate
Figure 3. Far-UV CD spectra of T10/hb2m (0.15 mg/mL; solid line)
and HLA-A2 (0.25 mg/mL; dotted line) heterodimers in 5 mM sodium
phosphate buffer (pH 7.0). Spectra were recorded using 0.1 cm cells at
258C.
Figure 4. (A) Thermal denaturation of the T10/hb2m heterodimer.
Protein concentration was 0.15 mg/mL. (B) CD scans of native, un-
folded, and renatured T10/hb2m.1228 T10 Does Not Bind Peptide and Is Recognized Directly by gd T Cell G8
peptide, for which free energies .5kcal/mol and Tm of
65–728C have been reported (29, 30). However, with the
exception of the Kd molecule, MHC class I molecules are
critically unstable in the absence of peptide and can not be
assembled. On the other hand, the stability of FcRn, which
does not bind peptide for either stability or function, lies in
between these extremes, with Tm of 628C and 518C at pH
6.0 and pH 8.0, respectively, the latter being very similar to
the the Tm of the T10/hb2m heterodimer (31).
Discussion
We set out to evaluate directly whether a component
other than the T10 heavy chain and b2m is necessary for its
recognition by G8 and for the structural stability of the
molecule by producing the two subunits separately in E.
coli and folding them together in vitro. We find that the
complex of T10 with murine b2m can be assembled in the
absence of any additional factors and that the heterodimer
is stimulatory to G8. However, T10/mb2m has a rather
low thermal stability, similar to that of the empty Kd mole-
cule. The ability of plate bound T10/mb2m to stimulate
G8 is also lower than cells expressing T10, by z10-fold.
Based on these observations, one possibility is that the
heterodimer expressed on the cell surface is further stabi-
lized by a factor(s) other than the primary amino acid se-
quences of T10 and mb2m. This stabilizing factor for T10/
mb2m in vivo may be the carbohydrate moieties that are
covalently linked to the T10 heavy chain. Although T10
and T22 have three potential N-linked glycosylation sites
in the a1 and a2 domains, two more than classical MHC
class I molecules, the E. coli–produced subunits are not gly-
cosylated. Recently, it was shown that the elimination of a
single N-glycan site in the adhesion domain of human
CD2, a protein belonging to the immunoglobulin super-
family, severely reduces the stability of the protein (33). It
is possible that one or more of the carbohydrates of T10/
T22 plays a critical role in stabilizing the structure of the
heterodimer. Alternatively, T10/mb2m might also be sta-
bilized by association with a molecule not covalently linked
to the complex. However, regardless of the nature of such
a stabilizing factor, by substituting the mouse b2m with hu-
man b2m in our in vitro system, we were able to increase
the stability of the T10 complex. T10/hb2m can stimulate
G8 at levels similar to that of the best stimulator cells.
These results indicate that, while an additional factor may
be necessary for the stable expression of T10 on the cell
surface, it does not confer specificity. Thus, the only essen-
tial feature required for G8 recognition is a properly folded
and stable T10 heavy chain and b2m heterodimer.
This scenario is reminiscent of the recognition of murine
class II I-Ek by the gd T cell LBK5. While I-Ek requires
peptide for stable expression on the cell surface, the bound
peptide does not confer specificity for its recognition by
LBK5. As shown previously, LBK5 can recognize I-Ek sta-
bilized by a variety of different peptides (15). Thus, these
two examples of gd T cell recognition differ fundamentally
from the recognition by ab T cells of classical or nonclassi-
cal MHC. In the latter case, the peptide or nonpeptide
moieties being presented contributes significantly to the
specificity of the recognition. However, unlike I-Ek, there
is no evidence that T10 binds peptide. This assertion is
based on the observation that no peptide(s) other than
those derived from the antibodies used for immunoprecipi-
tation can be eluted from T10/Ld molecules isolated from
cells (19), as well as our result presented here that the fold-
ing of heterodimer does not require peptide. These obser-
vations are consistent with the primary amino acid se-
quences of T10/T22, which suggest that these molecules
may lack the necessary structural features to bind peptide.
Most notably, T10/T22 possess a 3–amino acid deletion
within the a1 domain and a 12–amino acid deletion within
the a2 domain (14). Thus, assuming that T10 and T22
molecules fold similarly to classical MHC molecules, the
a2 a-helical region, the conserved COOH-terminal pep-
tide-binding pocket (pocket F), as well as the outermost b
strand of the a1 domain and the outermost b strand of the
a2 domain, would all be significantly altered (14).
Such structural features in T10 are not shared by FcRn, a
class Ib molecule that does not bind peptide. Crystallo-
graphic studies revealed that FcRn is structurally similar to
MHC molecules in its conservation of the a1 and a2 domain
topology of two helices that span a single b sheet, but the
presence of a proline at position 162 introduces a break in
the a2 helix of the molecule, causing a shift of its a helices
and resulting in a peptide-binding groove filled with side
chains (34). Consistent with the crystallographic analysis, it
was shown that the CD spectrum of FcRn and classical
MHC are very similar (35). However, both spectra are
blue-shifted when compared with that of T10/b2m. This
observation indicates that T10 is likely to possess structural
properties not found in either MHC class I molecules or in
FcRn. Thus, these results suggest a new way for an MHC
class I–like molecule to adopt a peptide-free structure.
An alternative to the hypothesis that T10/T22 needs an
Figure 5. Thermal denaturation of the T10/mb2m heterodimer. Protein
concentration was 0.15 mg/mL.1229 Crowley et al.
additional factor for stability is the possibility that rapid
turnover is a useful property in a ligand for gd T cell recog-
nition. There is strong evidence that at least one role for gd
T cells in the immune system is the surveillance for cells
that have become stressed or damaged (36–39). T10 mole-
cules expressed on the cell surface are likely to have a shorter
half-life than classical MHC molecules. Consistent with this,
preliminary antibody stainings indicate low T10 cell surface
expression on primary lymphoid cells and EL4 cells (Crow-
ley, M., and Y.-h. Chien, unpublished data). It is arguable
that a rapid turnover may better enable T10 to act as a tran-
sient target of sensory immune cells.
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